How to use PSMA-PET/CT in the Management of Relapsing Prostate Cancer Patients Webcast (2023)

Recurrent Prostate Cancer Cases PanelПодробнее

PSMA PET-CT: Clinical ApplicationsПодробнее

AUA2023: How to use PSMA-PET/CT in the Management of Relapsing Prostate Cancer PatientsПодробнее

AUA2024:How to use PSMA-PET/CT in the Management of Relapsing Prostate Cancer PatientsПодробнее

The role of PSMA PET in recurrent prostate cancerПодробнее

Prostate Cancer, PSMA PET and Functional ImagingПодробнее

PSMA PET and Functional Imaging - 2021 Prostate Cancer Patient ConferenceПодробнее

NCIS ISOS 2021 - Theranostics and Future of PSMA PET/CT for Prostate CancerПодробнее

PSMA PET guided salvage RT among patients with prostate cancer in the post-prostatectomy settingПодробнее

PSMA PET-CT scan and treatments for patients with cN1 prostate cancerПодробнее

Optimal treatment of clinically node-positive prostate cancer in the PSMA PET/CT eraПодробнее

Guidelines for using PSMA PET in the staging of prostate cancerПодробнее

PSMA PET-CT: A disruptive technology in the management of prostate cancerПодробнее

How to Integrate PSMA PET Findings Into Treatment AlgorithmsПодробнее

2021: PSMA and Prostate Imaging | Dr. Thomas Hope | 2021 Moyad + Scholz Mid-Year Update | PCRIПодробнее

Appropriate Use of PSMA PET in Clinical PracticeПодробнее

PSMA PET-CT in patients with high-risk prostate cancerПодробнее

Relevance of 68Ga PSMA11 in prostate cancer patient managementПодробнее

Imaging, PSMA PET/CT cases (pre/post therapy)Подробнее

PSMA PET Imaging: A Primer for the Urologist or OncologistПодробнее